Figure 2From: Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFRmutation The sequence of the junction between EML4 exon 20 and ALK exon 20. Back to article page